T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase
LEXINGTON, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…
Pharmaceuticals, Biotechnology and Life Sciences
LEXINGTON, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…
BELTSVILLE, Md., Sept. 07, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing…
– Two preclinical studies of RaniPill® HC achieved 18/20 successful drug delivery of orally administered teriparatide resulting in a cumulative…
– Data from superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) mouse model demonstrated prolonged survival and reduced inflammation in…
WESTLAKE VILLAGE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced…
— David Hochman and Darren Sherman resign from Motus Board of Directors to focus on their executive obligations –FORT LAUDERDALE,…
EDISON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial…
DURHAM, N.C., Sept. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,…
FREMONT, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today…
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense ReductionsLEXINGTON,…